Oddity Tech Ltd. (ODD) Company Overview

What does ODDITY Tech do?

ODDITY Tech Ltd. is an Israeli consumer-technology company listed on the Nasdaq Global Market under the ticker ODD. Its official company platform builds digitally native beauty and wellness brands and sells primarily through its own websites rather than through department stores, specialty retailers, resellers, or distributors. The company’s core proposition is that product discovery, shade matching, diagnosis, and repeat purchasing can be shifted online through data science, machine learning, computer vision, and tightly controlled direct customer relationships.

The operating platform behind the brands

IL MAKIAGE, launched online in the United States in 2018, focuses on prestige makeup and complexion products. SpoiledChild, launched in 2022, extends the platform into skincare, haircare, and supplements. METHODIQ, launched in 2025, adds telehealth and personalized dermatology treatments. ODDITY also owns ODDITY LABS, a biotechnology operation created after the Revela acquisition, and a New Ventures incubator developing additional brands. The official 2025 Form 20-F describes a portfolio spanning complexion, skincare, haircare, bodycare, prescription and over-the-counter products, supplements, color cosmetics, and tools, generally priced from about $20 to $100 per item.

How does ODDITY Tech make money?

ODDITY earns almost all revenue by selling physical products and, increasingly, treatment programs directly to consumers through brand-owned digital channels. The economic engine is therefore product gross profit less customer-acquisition spending, fulfillment, returns, brand development, technology, and corporate overhead. Unlike a marketplace, ODDITY is the merchant of record and bears product, inventory, advertising, and fulfillment risk. Unlike a traditional wholesale beauty company, it keeps the retail markup and owns the customer relationship.

Why repeat purchasing matters more than one-time sales

The model becomes attractive when a customer’s lifetime gross profit exceeds the cost of acquiring and serving that customer. Repeat orders generally require less paid-media spending than first orders, so a growing repeat base can support margins and cash generation. That is also why the 2026 advertising disruption is so important: fewer first orders in one quarter can reduce repeat revenue in later quarters. Management explicitly connected the Q1 2026 first-order decline to weaker expected repeat business through the rest of the year.

Which brands and capabilities matter most?

What ODDITY does not disclose

ODDITY does not report brand-level revenue or operating profit as formal segments. That limits outside analysis of IL MAKIAGE’s exact contribution, SpoiledChild’s standalone economics, or METHODIQ’s launch losses. The company instead reports one consolidated business and supplements it with channel, user, geographic, and qualitative brand information. Researchers should therefore avoid inventing brand mix percentages and focus on disclosed company-wide metrics, management commentary, and the trajectory of repeat demand.

What does the latest quarter show?

The first quarter of 2026 was a sharp break from ODDITY’s prior growth record. In the Q1 2026 earnings release, management attributed the disruption primarily to an advertising-account problem with its largest media partner. The company said algorithm changes diverted campaigns toward lower-quality auctions at unusually high costs, damaging conversion economics even though underlying repeat demand remained comparatively resilient.

The customer-acquisition shock was unusually large

IL MAKIAGE’s first-half cost-per-acquisition index rose from 1.5 in the first half of 2025 to 2.8 through May 2026, an 83% increase. Management said CPA in some cases reached roughly twice expected levels. The issue appeared across the United States, Canada, the United Kingdom, Australia, and Israel at the same time, supporting management’s argument that the change was technical rather than a gradual deterioration in brand saturation. May provided an early improvement signal: estimated IL MAKIAGE CPA declined 28% sequentially from April.

How did ODDITY build its current strategy?

1. 2013
   The company was incorporated in Israel, creating the corporate base that later became ODDITY Tech.
2. 2017
   L Catterton invested to support the U.S. online technology platform, adding capital and consumer-brand expertise.
3. 2018
   IL MAKIAGE launched online in the United States, proving that complexion matching and prestige beauty could scale digitally.
4. 2020
   The platform expanded into the United Kingdom and later continental Europe and Australia, creating an international growth path.
5. 2021
   ODDITY acquired Voyage81, adding computer vision, AI imaging, and hyperspectral capabilities to its technology stack.
6. 2022
   SpoiledChild launched, testing whether the platform could scale a second brand in wellness categories.
7. 2023
   ODDITY acquired Revela for $67.4M, created ODDITY LABS, and completed its Nasdaq IPO on July 19.
8. 2025
   METHODIQ launched, extending the model into telehealth and dermatology while increasing regulatory and clinical complexity.

The strategic pattern is platform reuse

Each turning point expanded one of three assets: consumer reach, prediction technology, or product science. The strategy is not simply to launch more cosmetics. It is to use a common platform to lower the cost and risk of creating brands across adjacent beauty, wellness, and medical categories. The 2021 Voyage81 and 2023 Revela acquisitions matter because they moved ODDITY beyond marketing technology toward computer vision and proprietary molecule discovery. The 2025 METHODIQ launch matters because it tests whether the same digital funnel can support diagnosis, care, and ongoing treatment.

What gives ODDITY a competitive advantage?

ODDITY’s strongest potential moat is the interaction among first-party data, product matching, direct distribution, rapid testing, and repeat purchasing. Approximately 68 million recognized users create a large pool of behavioral data. The company can use that information to refine quizzes, product recommendations, creative content, and product development. Selling directly also provides faster feedback than a wholesale model where retailers own much of the transaction data.

The moat has a visible weak point

ODDITY controls its websites and customer data, but not the major digital advertising systems that supply many new users. That distinction became critical in 2026. A business can be direct-to-consumer and still depend heavily on external discovery channels. The most durable version of ODDITY’s moat would therefore include a larger repeat base, stronger organic demand, diversified media sources, and multiple brands that share technology without sharing the same acquisition bottleneck.

Who are the main competitors?

Competition comes from global beauty groups, prestige brands, digital-native challengers, telehealth dermatology providers, and retailers with strong loyalty ecosystems. Estée Lauder, L’Oréal, Coty, e.l.f. Beauty, and numerous independent brands compete for product demand and advertising inventory. Sephora and Ulta Beauty compete through assortment, stores, loyalty programs, and omnichannel convenience. METHODIQ also enters a field containing specialist telehealth platforms and established prescription dermatology products. ODDITY differentiates itself through online-only personalization and platform reuse, but rivals may have broader distribution, larger R&D budgets, stronger retail visibility, or lower dependence on paid social acquisition.

How financially strong is ODDITY after the 2026 disruption?

The balance sheet provides substantial room to absorb a difficult operating period. At March 31, 2026, ODDITY reported $667.4 million of cash, cash equivalents, restricted cash, and investments. It also had $350 million of undrawn credit facilities. Against that liquidity, the company carried a $585.2 million exchangeable note liability. This is not a debt-free balance sheet, but liquidity remained large relative to quarterly operating needs.

Annual strength versus quarterly stress

Free cash flow equals operating cash flow minus purchases of property and equipment. For Q1 2026, operating cash outflow of $20.2 million minus $0.9 million of capital expenditures produced free cash outflow of about $21.1 million. The company also capitalized $4.2 million of software development and other intangible investment, which is outside its stated free-cash-flow calculation and should still be considered when assessing total reinvestment.

Who owns ODDITY stock, and why does control matter?

ODDITY has a dual-class structure. Each Class A ordinary share carries one vote, while each Class B ordinary share carries ten votes. As of March 4, 2026, co-founder and CEO Oran Holtzman beneficially owned all 11.547 million Class B shares and approximately 2.210 million Class A shares, representing about 73.3% of total voting power. Economic ownership and voting control are therefore very different.

Founder control changes the governance analysis

The founder can significantly influence director elections, charter amendments, and major transactions requiring shareholder approval. That may support long-term investment in new brands and biotechnology without short-term market pressure, but it also limits the ability of Class A shareholders to change strategic direction. The annual report also notes that ODDITY is a foreign private issuer and follows certain Israeli home-country governance practices rather than every Nasdaq requirement. Investors should read the company’s official filings page alongside the annual report because the reporting cadence differs from a U.S. domestic issuer.

What opportunities could restart growth?

The most immediate opportunity is normalization of customer-acquisition costs. Even a partial recovery could improve revenue, gross-margin mix, operating leverage, and future repeat orders. The second opportunity is brand expansion. SpoiledChild and METHODIQ broaden the addressable market, while Brand 4 could demonstrate whether ODDITY truly has a repeatable platform rather than one exceptional franchise.

Capital allocation can amplify or dilute the opportunity

In March 2026, the board authorized up to $200 million of Class A share repurchases through March 31, 2029. During Q1 2026, ODDITY repurchased about 6.1 million Class A shares for approximately $82.3 million, reducing Class A shares outstanding by roughly 10.6%. About $167.3 million remained under the authorization at quarter-end. In June 2026, the company also agreed to repurchase $50 million principal amount of 0% exchangeable notes for about $35 million, according to an official Form 6-K. These actions can improve per-share economics, but they also consume liquidity during a recovery period.

What risks could weaken ODDITY’s outlook?

The largest current risk is not abstract competition; it is the proven sensitivity of revenue and profit to paid-media efficiency. Q1 2026 demonstrated how quickly a change in auction quality can reduce first orders, compress gross margin, create operating losses, and weaken cash flow. Even if the account problem is repaired, the episode raises questions about concentration with the largest advertising partner and the durability of acquisition economics.

Execution risk rises as the model expands

Beauty products, supplements, prescription care, biotechnology, and international e-commerce do not share identical regulatory or operating requirements. METHODIQ must coordinate diagnosis, prescribing, fulfillment, privacy, and ongoing care. ODDITY LABS must translate discovery work into commercially meaningful products. International expansion adds currency, tax, logistics, and local compliance complexity. The company’s FY2025 results release also highlighted the tension between continuing long-term investment and managing near-term media inefficiency.

Why does ODDITY matter for valuation?

ODDITY should not be valued as a simple cosmetics manufacturer because its economics depend on digital acquisition, repeat behavior, platform reuse, and technology investment. Yet it should not be treated like a pure software company either: it carries inventory, product costs, returns, fulfillment, regulatory exposure, and physical-product execution risk. A useful valuation framework separates the mature cash-generating brand base from the spending required to recover acquisition efficiency and build newer brands.

Which KPIs matter most?

The highest-value metrics are customer-acquisition cost, first-order volume, repeat revenue, gross margin, adjusted EBITDA, operating cash flow, inventory, and cash plus investments. User count is useful for platform reach but not sufficient by itself; recognized visitors do not equal paying customers. Brand-level economics would improve transparency, but until ODDITY discloses them, consolidated cash conversion and management’s qualitative brand commentary remain the best available checks.

What is the key takeaway from ODDITY Tech analysis?

ODDITY is important because it has built a sizeable, profitable-before-2026, online-first beauty and wellness platform in industries still heavily influenced by physical retail. IL MAKIAGE proved the digital matching and direct-sales model; SpoiledChild, METHODIQ, and ODDITY LABS are attempts to turn that success into a broader platform. FY2025 revenue of $810 million, a 72.7% gross margin, and $163 million of adjusted EBITDA showed the model’s potential at scale.

The Q1 2026 reversal is equally informative. Revenue fell 26%, gross margin declined to 69.7%, adjusted EBITDA turned negative, and free cash flow was an outflow of $21.1 million. The cause was closely tied to the company’s largest advertising partner, revealing that direct customer ownership does not eliminate dependence on external traffic algorithms. The central research question is therefore whether ODDITY can restore acquisition efficiency while preserving brand demand and continuing to fund METHODIQ, Brand 4, and biotechnology initiatives.